SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / General: TDP-43 vs Tau Pathology Determination in GRN vs MAPT Mutatio

general 808 words KG: Ftd 2026-03-28

state:published

Contents

TDP-43 vs Tau Pathology Determination in GRN vs MAPT Mutation Carriers

Knowledge Graph

Related Hypotheses (27)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.42 SASP-Mediated Complement Cascade Amplification
Score: 0.70 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59

Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 Autophagosome Maturation Checkpoint Control
Score: 0.49 Stress Granule Phase Separation Modulators
Score: 0.49 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 RNA Granule Nucleation Site Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Cryptic Exon Silencing Restoration
Score: 0.46 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 Cross-Seeding Prevention Strategy
Score: 0.45 Lysosomal Membrane Repair Enhancement
Score: 0.45 Mitochondrial Transfer Pathway Enhancement
Score: 0.44 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 R-Loop Resolution Enhancement Therapy
Score: 0.43 VCP-Mediated Autophagy Enhancement
Score: 0.41 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.36

Related Analyses (27)

What determines the specificity of TDP-43-induced mitochondr
neurodegeneration · failed How does chronic cGAS/STING activation downstream of TDP-43
neuroinflammation · failed What mechanisms drive TDP-43 pathology specifically in Alzhe
neurodegeneration · failed How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed What upstream mechanisms cause TDP-43 to trigger mPTP openin
neurodegeneration · failed

What mechanisms underlie TDP-43's contribution to cognitive
neurodegeneration · failed What determines the selectivity and efficiency of intercellu
neurodegeneration · completed What are the specific design principles for small molecules
medicinal chemistry · failed Does DNAJB6 directly inhibit cross-seeding between tau, α-sy
neurodegeneration · failed What is the therapeutic window between insufficient and toxi
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived How do pathological stress granules in neurodegeneration esc
neurodegeneration · failed RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · failed RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · failed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed

Related Experiments (29)

cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95 TDP-43 mutant mouse model cGAS/STING pathway analysis
validation · proposed · Score: 0.90 TDP-43 mitochondrial invasion and DNA release via mPTP
exploratory · proposed · Score: 0.90 TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
exploratory · proposed · Score: 0.90 cGAS/STING pathway validation in TDP-43 mutant mice
validation · proposed · Score: 0.85

TDP-43 pathology prevalence and distribution in AD cases
exploratory · proposed · Score: 0.80 APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75 Cognitive impact of TDP-43 pathology in AD patients
clinical · proposed · Score: 0.70 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40 C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40 FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40 Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40 Prion Strain Diversity and Selective Vulnerability in CJD
clinical · proposed · Score: 0.40 Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40 Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40 TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40 Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40

See Also (5)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: co_discussed Actin Cytoskeleton Dynamics in Neurodegeneration
mechanism · KG edge: co_discussed Packard Center for ALS Research
institution · KG edge: accumulates_in ACTB Gene
gene · KG edge: activates ABCD3 Gene
gene · KG edge: activates

Knowledge Graph (12 edges)

Ftd interacts_with Autophagy

Ftd regulates Oxidative Stress

Ftd interacts_with Apoptosis

Ftd interacts_with Cell Cycle

Ftd interacts_with Mapk

Ftd therapeutic_target Mitophagy

Ftd associated_with Lipid Metabolism

Ftd associated_with Wnt

Ftd associated_with Akt

Ftd associated_with Autophagy

SciDEX — scidex.ai — Dashboard | Atlas